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A B S T R A C T 
Ewing’s sarcoma, also called primitive 
neuroectodermal tumour of the adrenal gland, is 
extremely rare. Only a few cases have been reported 
in the literature. We report on a woman with adult-
onset primitive neuroectodermal tumour of the 
adrenal gland presenting with progressive flank 
pain. Computed tomography confirmed an adrenal 
tumour with invasion of the left diaphragm and 
kidney. Radical surgery was performed and the 
pain completely resolved; histology confirmed the 
presence of primitive neuroectodermal tumour, for 
which she was given chemotherapy. The clinical 
presentation of this condition is non-specific, and 
a definitive diagnosis is based on a combination 
of histology, as well as immunohistochemical and 
cytogenic analysis. According to the literature, these 
tumours demonstrate rapid growth and aggressive 
behaviour but there are no well-established 
guidelines or treatment strategies. Nevertheless, 
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Introduction
Ewing’s sarcoma (ES), also called primitive 
neuroectodermal tumours (PNET), is a rare cancer 
of presumed neuroectodermal origin and is mostly 
found in children and young adults.1 Since it usually 
involves the diaphysis of long bones, adrenal ES/
PNET is extremely rare. To our knowledge, only a 
handful of cases have been reported in the literature. 
Herein we present a patient with adult-onset adrenal 
PNET and discuss the diagnostic and management 
issues.  
Case report
A 37-year-old woman presented to our hospital 
in May 2013 with progressive pain over left flank 
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and abdomen for 1 month. Physical examination 
revealed a ballotable mass over the left flank. 
Contrast computed tomography (CT) demonstrated 
a 12-cm left adrenal mass with infiltration to the left 
crus of diaphragm and upper pole of the left kidney 
(Fig). On closer examination, the left renal artery was 
encased by the tumour but there was no evidence 
of distant metastases. Hormonal workup of this 
adrenal mass suggested that it was a non-functioning 
tumour. There was no excess in 24-hour urinary 
catecholamines and metanephrines, while 24-hour 
urinary free cortisol excretion was 71 (reference range 
[RR], 24-140) nmol. The aldosterone-renin ratio 
was 9.0 (reference level, <20) ng/dL per ng/(mLh). 
Luteinising hormone, follicle-stimulating hormone, 
and testosterone levels were 3.0 (RR, 1.2-103.0) IU/L, 
6.8 (1.8-22.5) IU/L, and 0.83 (0.35-2.60) nmol/L, 
respectively. The dehydroepiandrosterone level was 
4.5 (RR, 2-11) µmol/L. Owing to increasing pain 
and the rapidly growing tumour, she underwent 
surgery, which revealed a 12-cm adrenal tumour 
compressing the aorta and superior mesenteric 
artery, and the posterior part of the diaphragm and 
left renal artery were invaded by the tumour bulk. 
Accordingly, she underwent a left adrenalectomy 
together with radical nephrectomy and partial 
resection of the diaphragm. No gross tumour was 
left behind. Thereafter, she made a good uneventful 
recovery and was discharged on the fifth day. Her 
back pain resolved completely after surgery. 
CASE REPORT
surgery remains the mainstay of local disease control; 
curative surgery can be performed in most patients. 
Adjuvant chemoirradiation has been advocated yet 
no consensus is available. The prognosis of patients 
with primitive neuroectodermal tumours remains 
poor. 
FIG.  Left adrenal tumour with infiltration to the left diaphragmatic crus (solid 
arrow) and the left kidney (dotted arrow) 
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腎上腺原始神經外胚層腫瘤
曾怡寶、梁熊顯、譚兆宗、黃啟斌
尤文氏肉瘤（Ewing’s sarcoma）又稱為腎上腺原始神經外胚層腫瘤。
這類腫瘤極為罕見，文獻中只記載了數個病例。本文報告一名女性患
有成年始發的腎上腺原始神經外胚層腫瘤並出現持續加劇的腰痛。電
腦斷層掃描證實其腎上腺腫瘤侵襲左側膈肌和腎臟。病人接受根治性
手術後，痛楚完全消失，其後接受化療。組織學證實為原始神經外胚
層腫瘤。尤文氏肉瘤沒有特定的臨床表現，所以往往要結合組織學、
免疫組織化學和細胞遺傳學的分析才可為病人確診。據文獻報導，這
類腫瘤的生長速度快，侵襲性強，可惜沒有行之有效的指引或治療策
略。手術仍是主要治療方法，大部份患者均可接受治療性手術。雖然
有人提倡輔助性放射性化療，但對此尚未達成共識。原始神經外胚層
腫瘤患者的預後仍然欠佳。
 Histology revealed a monotonous population 
of small round tumour cells with hyperchromatic 
nuclei, small nucleoli, and minimal cytoplasm 
arranged in sheets and cords with occasional 
vague rosette formation. Karyorrhexis, mitosis, 
and ‘starry sky’ pattern were focally observed. 
Immunohistochemically, the tumour cells stained 
positively for MIC2 antigen (CD99), vimentin, 
and FLI1. By contrast they stained negatively for 
cytokeratin, leukocyte common antigen, MPO, WT1, 
synaptophysin, S100, desmin, myogenin, CD68, and 
CD34. The reverse transcriptase–polymerase chain 
reaction confirmed a reciprocal translocation of 
t(11;22)(q24;q12) involving the EWSR1 gene on 
chromosome 22 and the FLI1 gene on chromosome 
11 (ie EWSR1-FLI1 translocation). Overall, these 
findings were consistent with ES/PNET.
 She received adjuvant chemotherapy 
(cyclophosphamide, adriamycin, and vincristine 
alternating with ifosfamide and etoposide). The latest 
CT at 5 months post-surgery revealed no evidence of 
local or distant recurrence.
 
Discussion
Ewing’s sarcoma/PNET of the adrenal gland is rarely 
reported.2,3 Our review of the English literature 
revealed only 10 reports describing 16 patients 
(Table).3-12 As in our patient, CD99, a highly sensitive 
marker for PNET, was found in all 16 of these 
patients. Although not routinely looked for, as in our 
patient over 90% of PNET cases exhibit a reciprocal 
translocation of t(11;22)(q24;q12) involving the 
TABLE.  Summary of case reports regarding clinical conditions3-12
Study Sex/
age 
(years)
Tumour 
size 
(cm)
Clinical 
features
Surgical 
resection*
CD99 Trans-
location 
of t(11;22)
(q24;q12)
Adjuvant chemo 
(agent)*
RT Outcome
Renshaw et 
al,3 1996
F/46
F/20
F/48
N/A N/A N/A +
+
+
+
+ 
+
N/A N/A N/A
Matsuoka et 
al,6 1999
F/32 10 Pain + (R0) + N/A + (2 cycles) (IE / cisplatin) – Dead at 5 months after surgery (local 
recurrence and metastasis)
Pirani et al,7 
2000
M/57 15 DVT + (R0) + + N/A N/A N/A
Komatsu et al,8 
2006
F/53 3 Nil + (R0) + N/A – – Alive at 10 months after surgery (no metastasis 
or relapse)
Ahmed et al,9 
2006
F/28 10 N/A + (R0) + + + (6 cycles) (agents N/A) – N/A
Kim et al,10 
2006
F/24
F/25
8
15
Pain 
Pain 
N/A +
+
+ 
+
N/A N/A N/A
Lena,12 2009 F/74 16 N/A + (R1/R0†) + N/A – + (palliative) 
(60 Gy)
Alive at 8 years after surgery and RT (local 
recurrence and metastasis)
Zhang and Li,4 
2010
M/30 
F/21
F/24
M/22
12
10
9
17
Pain / 
upon 
routine 
screening
+ (R2) 
– 
+ (R0) 
+ (R0)
+ 
+ 
+ 
+
N/A – 
– 
+ (12 cycles) (agent N/A) 
+ (agent / cycles N/A)
+ (palliative)
–
– 
–
Dead at 8 months after surgery
Dead at 6 months after diagnosis (metastasis) 
Alive at 13 months after surgery (metastasis) 
Alive at 1 month after surgery (local recurrence)
Yamamoto et 
al,5 2013
M/26 8 Nil – + N/A – – Dead (tumour found during autopsy)
Abi-Raad et 
al,11 2013
F/26 11 Pain + (R1) + + + (IE / VAC) + (adjuvant) Alive at 8 months after surgery (no metastasis 
or relapse)
Abbreviations:	chemo	=	chemotherapy;	DVT	=	deep	vein	thrombosis;	IE	=	ifosfamide	and	etoposide;	N/A	=	data	not	available	or	not	reported;	RT	=	
radiotherapy;	VAC	=	vincristine,	doxorubicin	and	cyclophosphamide
*	 All	surgeries	were	curative	intent	and	all	chemotherapies	were	adjuvant	intent
†	 The	patient	had	R1	resection	of	the	adrenal	tumour	and	refused	chemo-	and	radio-therapies	initially.	She	had	local	recurrence	subsequently	with	
reoperation	and	R0	resection.	She	had	local	relapse	again	and	received	radiotherapy	afterwards
  #  Tsang et al #
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EWSR1 gene on chromosome 22 and the FLI1 gene 
on chromosome 11.1,3,6-9,11,12 These 16 reported cases 
had a median age at diagnosis of 26 (range, 20-74) 
years, and the female-to-male ratio was 3:1. The 
median tumour size was 10.5 (range, 3-17) cm. 
  Nine of these patients underwent curative 
surgery despite rapid growth and aggressive tumour 
behaviour.4,7,8,12,13 Nevertheless, in a few patients 
the tumour behaves indolently or has a relatively 
quiescent period before rapid growth. A case of 
incidental PNET at autopsy has been reported 
in a 26-year-old man who committed suicide by 
hanging himself; his latent PNET measured 8 cm.5 
Similarly, another patient aged 53 years underwent 
a laparoscopic adrenalectomy for a presumed non-
functional incidental adrenocortical adenoma, but 
turned out to be a 3-cm PNET.8
Diagnostic issues
It is difficult to make a definitive diagnosis of ES/
PNET before surgery because currently it is based on 
a combination of histology, immunohistochemistry, 
and cytogenetic analysis.4,8 Although needle biopsy is 
a possible approach to making a definitive diagnosis 
without resection, it is rarely performed unless 
the tumour is considered not resectable or adrenal 
metastases are suspected. Since our patient had 
a potentially resectable tumour with no evidence 
of distant metastases, needle biopsy was not 
considered. Furthermore, she was clearly suffering 
pain arising from the tumour and therefore surgical 
resection was clearly indicated.
Management issues
Due to its rarity, there are no well-established 
guidelines or treatment strategies for PNET. Surgical 
resection remains the mainstay for local disease 
control.4,7,8 Since the tumour is believed to be both 
chemo- and radio-sensitive, adjuvant chemotherapy 
and radiotherapy have often been advocated for better 
local and distant control, but there is no consensus.13 
A standard regimen of chemoirradiation is not yet 
established due to the sporadic nature of cases.13 
Most chemotherapy regimens for adult-onset 
PNET are akin to those for ES in children as both 
share the same origin.4,14 Chemotherapeutic agents 
such as cyclophosphamide, adriamycin, vincristine, 
ifosfamide, or etoposide have been used.4,7,8 Recently, 
it has been noted that chemotherapy might be 
effective only for the first few cycles, and that the 
tumours develop resistance very quickly.4 Adjuvant 
radiotherapy had been used for local recurrences 
as well as unresectable or incompletely resected 
PNETs.4,12 From our review, adrenalectomies were 
performed for 11 patients, while chemotherapy 
and radiotherapy was also given to six and three of 
them, respectively. Follow-up revealed that these 
tumours were aggressive; three of the 16 patients 
died within 1 year of diagnosis or surgery. Regarding 
the six patients who were still surviving when this 
report was submitted, one had distant metastasis 
and another two had local recurrence. Because of 
this high rate of recurrence, intensive follow-up 
with regular CT scans (every 6 months) has been 
advocated even after seemingly curative surgery.12
Conclusion
Herein we report a rare case of adult adrenal PNET. 
The clinical presentation is often vague and non-
specific and a definitive diagnosis depends on a 
combination of histology, immunohistochemistry, 
and cytogenetic analysis. Surgical resection remains 
the mainstay of treatment coupled with adjuvant 
chemoirradiation. Nevertheless, the prognosis 
appears poor.
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